Stocks making the biggest moves premarket: Tesla, Occidental Petroleum, Exxon Mobil and more

Stocks making the biggest moves premarket: Tesla, Occidental Petroleum, Exxon Mobil and more


Check out the companies making headlines before the bell:

Tesla (TSLA) – Tesla delivered 254,695 vehicles during the second quarter, down 17.9% from the first quarter and below what analysts had predicted. China’s Covid-19 shutdowns were a key factor in holding back production. Tesla fell 1% in premarket trading.

Occidental Petroleum (OXY) – Occidental gained 1.3% in the premarket following news that Berkshire Hathaway (BRKb) once again added to its stake in the energy producer. Berkshire bought 9.9 million more shares, boosting its stake to 17.4%.

Exxon Mobil (XOM) – Exxon rose 1.3% in premarket trading following its late Friday announcement that second-quarter earnings could be as much as $18 billion. Exxon’s results are getting a boost from rising oil and natural gas prices and higher refining margins.

Crocs (CROX) – Crocs jumped 2.4% in premarket action after the casual shoe maker’s stock was upgraded to “buy” from “hold” at Loop Capital.

Stellantis (STLA) – Stellantis shares slid 6% in the premarket after a union workers report said the worldwide chip shortage could cut the automaker’s Italy-based production by about 220,000 vehicles this year. Stellantis produced about 14% fewer vehicles during the first half of 2022 compared with the same period a year ago.

Hecla Mining (HL) – The mining company announced a deal to acquire all of the Alexco Resource shares it didn’t already own in a stock swap transaction. Hecla will also pay Wheaton Precious Metals (WPM) $135 million to terminate its joint venture with Alexco. Hecla rose 1% in premarket action.

HP Inc. (HPQ) – The computer and printer maker’s shares fell 1.9% in premarket trading after Evercore downgraded the stock to “in line” from “outperform”. The downgrade comes amid a slowdown in demand for personal computers.

AstraZeneca (AZN) – The drug maker announced a deal to buy biotech firm TeneoTwo in a deal that could be worth up to $1.17 million if certain milestones are reached. AstraZeneca fell 1.1% in the premarket.



Source

Saba Capital finds little appetite for tender offer of shares in Blue Owl, Starwood private credit funds
Finance

Saba Capital finds little appetite for tender offer of shares in Blue Owl, Starwood private credit funds

Key Points In March, Saba offered liquidity to investors who were locked in Blue Owl Capital Corporation II, a non-traded private credit fund, at a 35% discount. Investors in Starwood Real Estate Income Trust were also made a similar offer at a 24% or 29% discount, based on the share class. On Monday, Saba said […]

Read More
Stocks making the biggest moves after hours: LendingClub, Nucor, Rambus, Bed Bath & Beyond and more
Finance

Stocks making the biggest moves after hours: LendingClub, Nucor, Rambus, Bed Bath & Beyond and more

Check out the companies making headlines after the bell : Bed Bath & Beyond — The home goods retailer surged 31% after reporting first-quarter revenue of $247.8 million, beating the $240.1 million analysts polled by FactSet had expected. The company also posted an adjusted loss of 25 cents per share, narrower than the 28-cent loss […]

Read More
Ray Dalio says Kevin Warsh shouldn’t cut interest rates in a ‘stagflation’ era
Finance

Ray Dalio says Kevin Warsh shouldn’t cut interest rates in a ‘stagflation’ era

Key Points The founder of Bridgewater Associates said persistent inflation pressures alongside slowing growth create a backdrop that demands caution from policymakers. “We are certainly in a stagflationary period,” Dalio said Monday on CNBC’s “Money Movers.” Source

Read More